Lumbar Canal Stenosis |
|
|
Clinical Trial: An Investigational Drug on Clinical Outcomes in Patients with Aortic Stenosis (narrowing of the major blood vessel of the heart)
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to evaluate whether treatment with an investigational drug as compared to placebo will reduce the risk of major cardiovascular events in patients with aortic stenosis.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Aortic Stenosis | | Phase II Phase III |
MedlinePlus related topics: Heart Valve Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Study to Evaluate the Effects of an Investigational Drug on Clinical Outcomes in Patients with Aortic Stenosis (narrowing of the major blood vessel of the heart)
Eligibility
Ages Eligible for Study: 45 Years - 85 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Patients aged 45 to 85 with mild abnormalities of the aortic valve as confirmed by an echocardiogram.
Exclusion Criteria:
- Patients previously in a trial using the study drug, or currently taking any medications that are not allowed in this study.
Location Information
Pennsylvania
Call for International Site Information, Horsham, Pennsylvania, 19044, United States
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 23, 2004
ClinicalTrials.gov Identifier: NCT00092677
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Lumbar Canal Stenosis (Cleveland Clinic)
- Lumbar Canal Stenosis (Cleveland Clinic)

Not Signed In -

